Aptamer and Timser partner to deliver world’s first blood test for cervical cancer

From Aptamer GroupMay 22 2024 Aptamer Group plc , the developer of novel Optimer® binders to enable innovation in the life sciences industry, has signed an agreement with Timser Group, a pharmaceutical company focused on women’s health, with a deal value of up to £465,000.

Pairs of Optimer binders will be developed to each of the three biomarker proteins that form the unique cervical cancer signature. Timser will receive a license for the use of the Optimers in its specific test combination, which is patented in 21 countries, including the USA. As Timser expands its diagnostic tests into diverse markets, including low-income countries, the Optimer binders offer advantages to support continued supply and quality.

Technology Technology Latest News, Technology Technology Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pioneering Miami residences by Aston Martin aim to capture the imaginationJonathan Bell has written for Wallpaper* magazine since 1999, covering everything from architecture and transport design to books, tech and graphic design. He is now the magazine’s Transport and Technology Editor. Jonathan has written and edited 15 books, including Concept Car Design, 21st Century House, and The New Modern House.
Source: wallpapermag - 🏆 36. / 67 Read more »